7 studies were found.

1.		No longer recruiting	Assessing Quality of Life of Patients With Stomach Cancer Conditions: adenocarcinoma of the stomach; Quality of Life
2.		No longer recruiting	Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer Conditions: recurrent pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
3.		No longer recruiting	Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer Conditions: recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; Quality of Life; ...
4.		No longer recruiting	High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer Conditions: childhood gastrointestinal cancer; stage III gastric cancer; stage IV gastric cancer
5.		No longer recruiting	Monoclonal Antibody Therapy Compared With No Further Therapy After Surgery in Treating Patients With Stage II Colon Cancer Conditions: stage II colon cancer; adenocarcinoma of the colon
6.		No longer recruiting	Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases from Colorectal Cancer Conditions: stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; liver metastases
7.		No longer recruiting	Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer Conditions: stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer; intestinal adenocarcinoma of the stomach; ...